Skip to content

Precigen PGEN Inventories

Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.76B+3.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.1B-2.8%
Gilead Sciences logo
Gilead SciencesGILD
$2.42B+20.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$35.09M+18.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$55M+19.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$32.98M+734%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:InventoryGross.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's inventories?
Precigen (PGEN) reported inventories of $14.73M in Q1 2026.
What is the long-term trend for Precigen's inventories?
Over 5 years (2020 to 2025), Precigen's inventories has grown at a -3.3% compound annual growth rate (CAGR), from $11.36M to $9.58M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.